AIDS-related Kaposi's Sarcoma: A Phase II study of liposomal doxorubicin

Clinical Cancer Research

Volumn 5, Issue 11, 1999, Pages 3432-3437

  Cheung, Tony W ^c   Remick, Scot C ^a,d   Azarnia, Nozar ^e   Proper, Jo Ann ^b   Barrueco, Jose R ^f   Dezube, Bruce J ^b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d ALBANY MEDICAL COLLEGE   (United States)

^e Liposome Company Incorporated   (United States)

^f PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHOLESTEROL; DAUNORUBICIN; DOXORUBICIN; LIPOSOME; PHOSPHATIDYLCHOLINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALOPECIA; ARTICLE; BLOOD TOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; HUMAN; KAPOSI SARCOMA; MALE; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGED; ANTINEOPLASTIC AGENTS; CD4 LYMPHOCYTE COUNT; CHOLESTEROL; CONFIDENCE INTERVALS; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG CARRIERS; HUMANS; LIPOSOMES; MALE; MIDDLE AGED; PHOSPHATIDYLCHOLINES; SARCOMA, KAPOSI; SKIN NEOPLASMS; TIME FACTORS;

EID: 0032759911     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Beral, V., Peterman, T. A., Berkelman, R. L., and Jaffe, H. W. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection. Lancet, 335: 123-128, 1990.
2. Northfelt, D. W. Treatment of Kaposi's sarcoma: current guidelines and future perspectives. Drugs, 48: 569-582, 1994.
3. Fischl, M. A., Krown, S. E., O'Boyle, K. P., Mitsuyasu, R., Miles, S., Wernz, J. C., Volberding, P. A., Kahn, J., Groopman, J. E., Feinberg, J., Woody, M., and the AIDS Clinical Trial Group. Weekly doxorubicin in the treatment of patients with AIDS-related Kaposi's sarcoma. J. Acquir. Immune Defic. Syndr., 6: 259-264, 1993.
4. Wheeler, R. H, Lewis, R. P., and Balcezak, S. P. Adriamycin cardiotoxicity in man. Ann. Intern. Med., 81: 493-498, 1982.
5. Shan, K., Lincoff, A. M., and Young, J. B. Anthracycline-induced cardiotoxicity. Ann Intern Med., 125: 47-58, 1996.
6. Gabizon, A. Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. Cancer Res., 52: 891-896, 1992.
7. Bogner, J. R., Kronawitter, U., Rolinski, B., Truebenbach, K., and Goebel, F. D. Liposomal doxorubicin in the treatment of advanced AIDS-related Kaposi's sarcoma. J. Acquir. Immune Defic. Syndr., 7: 463-468, 1994.
8. Harrison, M., Tomlinson, D., and Stewart, S. Liposomal-entrapped doxorubicin: an active agent in AIDS-related Kaposi's sarcoma. J. Clin. Oncol., 13: 914-920, 1995.
9. Gill, S. P., Espina, B. M., Muggia, F. M., Cabriale, S., Tulpule, A., Esplin, J. A., Liebman, H. A., Forssen, E., Ross, M. E., Levine, A. M. Phase I/II clinical and pharmacokinetic evaluation of daunorubicin. J. Clin. Oncol., 13: 996-1003, 1995.
10. Mayer, L. D., Bally, M. B., Hope, M. J., and Cullins, P. R. Update of antineoplastic agents into large unilamelear vesicles in response to a membrane potential. Biochim. Biophys. Acta, 816: 294-302, 1985.
11. Cowens, J. W., Creaven, P. J., Greco, W. R., Brenner, D. E., Tung, Y., Ostro, M., Pilkiewicz, F., Ginsberg, R., and Petrelli, N. Initial clinical (Phase I) trial of TLC D-99 (doxorubicin encapsulated in liposomes). Cancer Res., 53: 2796-2802, 1993.
12. Krown, S. E., Metroka, C., and Wernz, J. C. Kaposi's sarcoma in the acquired immunodeficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. J. Clin. Oncol., 7: 1201-1207, 1989.
13. LeBlanc, A. J., Hurley, R. E. Adoption of HIV-related services among urban US hospitals: 1988 and 1991. Med. Care (Phila.), 33: 881-891, 1995.
14. th World AIDS Conference, Geneva, June 28-July 3, 1998. Abstract 42296, p. 833.
15. Niederhuber, J. E., Brennan, M. F., and Menck, H. R. The National Cancer Data Base report on pancreatic cancer. Cancer (Phila.), 76: 1671-1677, 1995.
16. Weiss, S. E., Tatter, P. I., Ahmed, S., Brower, S. T., Brusco, C., Bossolt, K., Amberson, J. B., and Bratton, J. Ethnic differences in risk and prognostic factors for breast cancer. Cancer (Phila.), 76: 268-274, 1995.
17. James, N. D., Coker, R. J., Tomlinson D., Harris, J. R. W., Gompels, M., Pinching, A. J., and Stewart, J. S. W. Liposomal doxorubicin (Doxil): an effective new treatment for Kaposi's sarcoma in AIDS. Clin. Oncol., 6: 294-296, 1994.
18. Uziely, B., Jeffers, S., Isacson, R., Kutsch, K., Wei-Tsao, D., Yehoshua, Z., Libson, E., Muggia, F. M., and Gabizon, A. Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary Phase I studies. J. Clin. Oncol., 13: 1777-1785, 1995.
19. Grunaug, M., Bogner, J. R., Loch, O., and Goebel, F. D. Liposomal doxorubicin in pulmonary Kaposi's sarcoma: improved survival as compared with patients without liposomal doxorubicin. Eur. J. Med. Res., 3: 13-19, 1998.
20. Northfelt, D. W., Dezube, B. J., Thommes, J. A., Levine, R., Von Roenn, J. H., Dosik, G. M., Rios, A., Krown, S. E., DuMond, C., and Mamelok, R. D. Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy. J. Clin. Oncol., 15: 653-659, 1997.
21. Northfelt, D. W., Dezube, B. J., Thommes, J. A., Miller, B. J., Fischl, M. A., Friedman-Kien, A., Kaplan, L. D., DuMond, C., Mamelok, R. D., and Henry, D. H. Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized Phase III clinical trial. J. Clin. Oncol., 16: 2445-2451, 1998.
22. Batist, G., Winer, E., Navari, R., Rovira, N., Azarnia, N., and the TLC D-99 Study Group. Decreased cardiac toxicity by TLC D-99 (liposome encapsulated doxorubicin) vs. doxorubicin in a randomized trial of metastatic breast carcinoma (MBC). Proc. Am. Soc. Clin. Oncol., Abstract 443, 17: 115a, 1998.